Transgene proposes rights offering

Transgene S.A. (Euronext:TNG), Illkirch, France Business: Gene/Cell therapy, Cancer, Infectious Date announced: 3/24/10 Type: Rights offering To be raised: €100-€150 million ($135.3-$202.9 million) Sh...